THRIVE-2 News, Researches, Clinical Trials and Articles

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Press Releases September 29, 2026 0

Secretome Therapeutics has announced the start of THRIVE-2, a...

Care Guidelines September 29, 2026 0

Duchenne muscular dystrophy speech delay is an important developmental...

Research September 28, 2026 0

Keros Therapeutics has announced an important step in the...

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

THRIVE-2